Scrip reports on the predictions of VIVEbiotech
Natalia Elizalde has been included in the clinical trial section about the leading annual article series by Scrip alongside a number of leading international figures in the life science industry.
In these article series executives share their predictions around clinical trial trends for the year ahead, going through topics like technology, regulation, patient recruitment and access, among others.
You can read the whole article here: https://scrip.pharmaintelligence.informa.com/SC147975/Scrip-AsksWhat-Does-2023-Hold-For-Biopharma-Part-7-Clinical-Trial-Trends
Thanks a lot to Scrip for gathering our impressions!